Bashier, A., Khalifa, A. A., Abdelgadir, E. I., Al Saeed, M. A., Al Qaysi, A. A., Bayati, M. B. A., . . . Hassanein, M. (2018). Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes. Oman Med J.
Styl ChicagoBashier, Alaaeldin, et al. "Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients With Type 2 Diabetes." Oman Med J 2018.
Citace podle MLABashier, Alaaeldin, et al. "Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients With Type 2 Diabetes." Oman Med J 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..